BR0114603A - Derivados de m-amino-fenilimino-imidazolidina para tratamento da incontinência urinária - Google Patents

Derivados de m-amino-fenilimino-imidazolidina para tratamento da incontinência urinária

Info

Publication number
BR0114603A
BR0114603A BR0114603-3A BR0114603A BR0114603A BR 0114603 A BR0114603 A BR 0114603A BR 0114603 A BR0114603 A BR 0114603A BR 0114603 A BR0114603 A BR 0114603A
Authority
BR
Brazil
Prior art keywords
urinary incontinence
amino
treatment
phenylimino
imidazolidine derivatives
Prior art date
Application number
BR0114603-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Pascale Pouzet
Franz Esser
Hisato Kitagawa
Kenji Sakai
Ikunobu Muramatsu
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of BR0114603A publication Critical patent/BR0114603A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR0114603-3A 2000-10-14 2001-10-11 Derivados de m-amino-fenilimino-imidazolidina para tratamento da incontinência urinária BR0114603A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10051005 2000-10-14
PCT/EP2001/011764 WO2002032876A2 (fr) 2000-10-14 2001-10-11 Nouveaux derives de m-amino-phenylimino-imidazolidine pour le traitement de l'incontinence urinaire

Publications (1)

Publication Number Publication Date
BR0114603A true BR0114603A (pt) 2003-10-14

Family

ID=7659815

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0114603-3A BR0114603A (pt) 2000-10-14 2001-10-11 Derivados de m-amino-fenilimino-imidazolidina para tratamento da incontinência urinária

Country Status (23)

Country Link
EP (1) EP1328517A2 (fr)
JP (1) JP2004511547A (fr)
KR (1) KR20030046503A (fr)
CN (1) CN1471514A (fr)
AR (1) AR035923A1 (fr)
AU (1) AU2002215943A1 (fr)
BG (1) BG107711A (fr)
BR (1) BR0114603A (fr)
CA (1) CA2425563A1 (fr)
CZ (1) CZ20031333A3 (fr)
DE (1) DE10150312A1 (fr)
EA (1) EA200300460A1 (fr)
EC (1) ECSP034517A (fr)
EE (1) EE200300177A (fr)
HU (1) HUP0302245A3 (fr)
IL (1) IL155338A0 (fr)
MX (1) MXPA03003162A (fr)
NO (1) NO20031697L (fr)
PL (1) PL361359A1 (fr)
SK (1) SK4342003A3 (fr)
WO (1) WO2002032876A2 (fr)
YU (1) YU28203A (fr)
ZA (1) ZA200302345B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4168086B1 (ja) * 2008-04-16 2008-10-22 国立大学法人福井大学 イミダゾリン誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2806811A1 (de) * 1978-02-17 1979-08-23 Boehringer Sohn Ingelheim Neue substituierte 2-phenylimino- imidazolidine, deren saeureadditionssalze, diese enthaltene arzneimittel und verfahren zur herstellung derselben
CA1201066A (fr) * 1981-11-20 1986-02-25 Alcon Laboratories, Inc. Solutions de n-¬3,5-dichloro-4-(2- imidazolidinylidene-amino)-phenyl|-acetamide pour diminuer la pression intra-oculaire
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz

Also Published As

Publication number Publication date
CZ20031333A3 (cs) 2003-08-13
EE200300177A (et) 2003-08-15
AU2002215943A1 (en) 2002-04-29
SK4342003A3 (en) 2003-10-07
KR20030046503A (ko) 2003-06-12
WO2002032876A2 (fr) 2002-04-25
IL155338A0 (en) 2003-11-23
EP1328517A2 (fr) 2003-07-23
HUP0302245A3 (en) 2004-01-28
AR035923A1 (es) 2004-07-28
EA200300460A1 (ru) 2004-02-26
ECSP034517A (es) 2003-04-25
ZA200302345B (en) 2004-04-23
DE10150312A1 (de) 2002-07-04
NO20031697L (no) 2003-05-26
PL361359A1 (en) 2004-10-04
YU28203A (sh) 2006-05-25
JP2004511547A (ja) 2004-04-15
CN1471514A (zh) 2004-01-28
WO2002032876A3 (fr) 2002-07-18
NO20031697D0 (no) 2003-04-11
CA2425563A1 (fr) 2002-04-25
HUP0302245A2 (hu) 2003-10-28
MXPA03003162A (es) 2004-12-06
BG107711A (bg) 2004-02-27

Similar Documents

Publication Publication Date Title
ATE430727T1 (de) Alpha-(n-sulfonamid)acetamidderivate als beta- amyloidinhibitoren
EA200300528A1 (ru) 1-арил-или 1-алкилсульфонилгетероциклилбензазолы в качестве лигандов 5-гидрокситриптамина-6
BR0215240A (pt) Derivados de calcona e seu uso no tratamento de doenças
DE60124085D1 (de) Pde-v hemmer zur behandlung von morbus parkinson
EA200600294A1 (ru) [1,8] нафтиридин-2-оны и родственные соединения для лечения шизофрении
UY26813A1 (es) Compuestos para tratar enfermedad de alzheimer
BRPI0514632A (pt) derivados de ftalazinona 4-heteroarilmetila substituìdos
EA200300333A1 (ru) Новые тиадиазолы и оксадиазолы и их применение в качестве ингибиторов фосфодиэстеразы-7
ATE327225T1 (de) Neue verwendung von benzothiazolderivaten
NZ510435A (en) Arylsulfonanilide ureas and pharmaceutical use
BR0212101A (pt) 7-aza [2.2.1] biciclo-heptanos substituìdos com heteroarila para o tratamento de doenças
ATA16597A (de) Neue substituierte p-sulfonylaminobenzol- sulfonsäureamide
BR0310057A (pt) melhoria do desenvolvimento de catarata e outras doenças oftálmicas
DE69819154D1 (de) Hemmung von hiv-1 replikation mittels oligocarbamat-derivaten
BR9812238A (pt) Composto, uso deste, processo para a preparação do mesmo, formulação farmacêutica, e, processos para o tratamento de distúrbios do sistema nervoso central e/ou incontinência urinária, ou vasoespasmo, ou para controle de crescimento de tumores, e para o tratamento de distúrbios mediados por 5-hidroxitriptamina
BG108426A (bg) Нови производни на сулфоновата киселина
ATE482954T1 (de) Thiazolidinderivate und ihre verwendung als fungizide
BRPI0416371A (pt) composto de sulfoniltetrahidro-3h-benzo(e)indol-8-amina como ligantes de 5-hidroxitriptamina-6
BR0114603A (pt) Derivados de m-amino-fenilimino-imidazolidina para tratamento da incontinência urinária
MXPA05004845A (es) N-oxidos y derivados de melfalan para el tratamiento de estados de enfermedad asociados a un factor inducible por hipoxia.
DE60230652D1 (de) Arylsulfanyl und heteroarylsulfanyl-derivate zur behandlung von schmerz
DE60013515D1 (de) 4-Arylpiperidinderivate zur Behandlung von Pruritus
DE69909811D1 (de) Substituierte isoxazolylthiophenverbindungen
MXPA04000615A (es) Compuestos utiles para el tratamiento o la prevencion de enfermedades mediadas por alfa-2b-adrenoceptor.
ATE279182T1 (de) Verwendung spezieller verbindungen zur prophylaxe und therapie von hepatitis c

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 1964 DE 26/08/2008 E CONSIDERANDO A AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS.